PER 1.35% 7.5¢ percheron therapeutics limited

For General Information, page-2886

  1. 720 Posts.
    lightbulb Created with Sketch. 210
    And you seem to have no idea the risks and expense of getting a drug to market, let alone making a profit.

    Sarepta have 3 drugs commercially making US$ one billion in annual revenue and they still lose $500 mill a year.

    They spent US$440 mill in R&D costs on SRP-9001 last year and it hasn’t made a dollar in revenue yet.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.5¢
Change
0.001(1.35%)
Mkt cap ! $67.61M
Open High Low Value Volume
7.7¢ 7.8¢ 7.4¢ $24.63K 325.4K

Buyers (Bids)

No. Vol. Price($)
2 142779 7.3¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8181 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.